ClinicalTrials.gg
Enrolling by invitationNCT06146959Updated Apr 17, 2025

Corrective Calcaneal Kinesiology Tape in Adolescents With Pronated Foot

An interventional study of Corrective Kinesiology taping and Home exercise program in Physical Disability and Physical Therapy Modalities, sponsored by Beni-Suef University. Enrolling by invitation at 1 site in Egypt. Open to participants aged 12 Years to 18 Years. Per ClinicalTrials.gov, last updated 2025-04-17.

Sponsored by Beni-Suef University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
12 Years to 18 Years
Sex
All
01

Study summary

The aim of this study is to find the effect of a program of corrective kinesiotaping on pain intensity, foot function, and the sonographic picture of plantar fascia in adolescents with pronated feet.This study hypothesizes that there will be a statistically significant effect of a program of application of the corrective technique of kinesiotaping on plantar heel pain, foot function, and the sonographic picture of plantar fascia in a sample of Egyptian adolescents suffering from pronated feet.

Read the detailed description

This study will be conducted to find the effect of a program of corrective kinesiotaping on pain intensity, foot function, and the sonographic picture of the plantar fascia in adolescents with pronated feet. Thirty adolescents suffering from plantar heel pain associated with pronated feet will be included in this study. They will be distributed randomly into 2 groups: Group A will receive corrective kinesiotaping (50-75% stretch) for 6 weeks, 2 times per week with 1 day of rest; Group B will receive a home program of intrinsic foot strengthening and stretching exercises. Data will be collected pre- and post-intervention for all groups by using the visual analog scale (VAS), the first two subscales of the foot function index (FFI), and a sonographic picture of the foot for each adolescent. Participants will be recruited from outpatient clinics and schools.

02

Conditions studied

  • Physical Disability
  • Physical Therapy Modalities

Browse trials for

Keywords

  • Kinesiology tape , plantar fasciitis
03

In context

Fasciitis, Plantar

223 studies on the registry are indexed under Fasciitis, Plantar; 58 are open to participants now.

This study's planned enrollment of 30 is below the median of 56 across 194 interventional studies indexed under Fasciitis, Plantar.

Browse Fasciitis, Plantar studies →

Lead sponsor

Beni-Suef University is the lead sponsor of 349 studies on the registry; 125 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
12 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Children with unilateral or bilateral plantar fasciitis.
  • pronated foot or foot on weightbearing in the navicular drops test.
  • Pain and tenderness to palpation at the medial tubercle of the calcaneus for a minimum of 6 weeks and maximum of 6 months

Exclusion criteria

Exclusion Criteria:

  • injection of the heel within the past 3 months.
  • Posterior heel pain.
  • Systemic inflammatory conditions.
  • Diabetes.
  • Surgery of the foot.
  • Neuromuscular conditions e.g. CP.
  • Individuals with > 25.
  • Individuals engaged in regular athletic activities
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Group A

    Group A: will receive corrective kinesiotaping (50-75% stretch) for 4 weeks, 2 times per week, with 1 day rest

    Device: Corrective Kinesiology taping

  • Active comparator
    Group B

    Group B will receive a home program of intrinsic foot strengthening and stretching exercises.

    Other: Home exercise program

Interventions

  • DeviceCorrective Kinesiology taping

    corrective kinesiology tape is a form of biomechanical tape that is used with specific tension to get a corrective effect

    Also known as: Kinesiotape

  • OtherHome exercise program

    Intrinsic foot strengthening and stretching exercises

06

What researchers measure

Primary outcomes

  1. Pain Visual Analogue Scale

    minimum score is 0, and the maximum score is 10 ; higher scores means worse outcome

    Time frame: 4 weeks

Secondary outcomes

  1. Foot function Index

    This questionnaire has been designed to give therapists information on how foot pain has affected your ability to to manage in everyday life. each question on a scale from 0 (no pain) to 10 (worst pain imaginable)

    Time frame: 4 weeks

Other outcomes

  1. Diagnostic ultrasound

    A sonographic picture of plantar fascia

    Time frame: 4 weeks

07

Study locations

1 site
  • Tayseer Younes
    Cairo, Al Qahirah 11411, Egypt
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Dec 2023 to primary completion in Jul 2024, 7 months.

Of 104 non-industry interventional studies with no phase under Fasciitis, Plantar, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 21. This study's 7 months is below that.

Counting every sponsor, half of 109 studies reached it within 11 months; a quarter within 6 and three quarters within 22.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 18, 2023
First posted
Nov 27, 2023
StartActual
Dec 1, 2023
Primary completionActual
Jul 28, 2024
CompletionEst.
Dec 30, 2025
Last update
Apr 17, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 17, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06146959
Collaborators
Al-Azhar University
Responsible party
Tayseer Saber Abdeldayem (Lecturer, Beni-Suef University) — Principal investigator
First posted
Nov 27, 2023
Start date
Dec 1, 2023
Primary completion
Jul 28, 2024
Completion
Dec 30, 2025 (estimated)
Last update
Apr 17, 2025

Study contacts

Tayseer S Abdeldayem, PhD
principal investigator · Beni-Suef University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion